Published by ChinaMNC · Tantang

China's New Calibration Standard for Urine Meters: What Foreign MedTech Founders Should Know

China's market regulator has issued a national metrology standard for urine meters used in intensive care. Here is what the three evaluation dimensions cover and why they matter for foreign founders building or selling medical devices in China.

China Issues National Calibration Standard for ICU Urine Meters

China's State Administration for Market Regulation (SAMR) has released a national metrology technical standard, the Calibration Specification for Urine Meters. According to reporting carried by CCTV News and republished by SAMR, the specification addresses a technical gap in the calibration of urine meters in China and is intended to strengthen metrology oversight in critical-care settings.

For foreign founders whose companies manufacture, import, or operate connected medical devices in China, the release is a useful signal of how Chinese regulators are approaching measurement accuracy in clinical equipment. It also illustrates the type of technical benchmark that can shape product design, hospital procurement expectations, and inspection activity in the Chinese market.

Why Urine Meters Are Treated as Critical-Care Equipment

Urine output is described in the source as a core indicator for assessing a critically ill patient's circulation and kidney function. Urine meters are bedside monitoring devices in intensive care units (ICUs) that continuously collect and record patient urine data. Clinicians rely on that data when judging a patient's condition and adjusting treatment plans.

The source notes that inaccurate measurement can easily lead to a misjudgment of a patient's condition and can directly endanger the safety of critically ill patients. That clinical risk is the backdrop for the new specification: measurement accuracy in this device category is treated as a patient-safety matter, not merely a product-quality matter.

The Three Evaluation Dimensions

The specification sets out three dimensions of metrological performance evaluation. Foreign founders developing or localizing urine-monitoring devices for the Chinese market should understand each one, because they define what “accurate” means under the standard.

1. Alarm Function

Devices must be able to trigger timely audible and visual alarms when urine output is too high, too low, or when intermittent urine volume exceeds a preset threshold. The purpose is to help medical staff quickly identify abnormal changes in a patient's condition. For product teams, this means alarm logic and threshold configuration are part of the evaluated performance, not an optional feature.

2. Total Urine Volume Indication Accuracy

This dimension assesses how accurately a device measures cumulative urine volume over a specified period. It is aimed at ensuring stable and reliable data during long periods of continuous monitoring. Devices intended for extended ICU use should therefore be designed and tested for cumulative measurement performance, not just short-term readings.

3. Intermittent Urine Volume Indication Accuracy

This dimension assesses measurement performance for cumulative urine volume within intermittent intervals. It is intended to ensure that real-time displayed or output urine data is accurate and traceable, providing a reliable data foundation for clinical diagnosis. Traceability is the key word here: hospitals and regulators need to be able to follow a measurement back to a credible reference.

What the Specification Changes Across the Chain

The source states that implementation of the specification will connect three links: industry, medical institutions, and metrology supervision.

• Industry side: Manufacturers are guided to optimize product design against actual clinical working conditions and to strengthen metrological performance control at the factory level.
• User side: Medical institutions are guided to establish periodic traceability mechanisms for urine meters, to take responsibility as the primary party, and to manage the day-to-day metrology control of equipment in use.
• Supervision side: Market regulation authorities gain an authoritative technical basis for metrology supervision and inspection of medical equipment, enabling full-chain metrology oversight of critical-care devices from production through clinical use.

Practical Implications for Foreign Founders

If your company is entering China's medical device or digital health market, this specification is worth factoring into your compliance and product planning. Consider the following practical points.

Review product design against clinical conditions

The specification explicitly directs manufacturers to align product design with real clinical working conditions. For foreign founders, that means design assumptions validated in other markets should be checked against Chinese ICU workflows and the three evaluation dimensions above, particularly alarm behavior and long-duration cumulative measurement.

Plan for traceability, not just accuracy

The intermittent volume dimension emphasizes accurate and traceable data. If your device outputs data to hospital systems or remote monitoring platforms, traceability of measurement may become part of how hospitals evaluate and maintain the equipment.

Expect hospital-side periodic checks

Medical institutions are guided to establish periodic traceability mechanisms and to manage in-use equipment. Foreign suppliers working with Chinese hospitals or distribution partners should anticipate that calibration and maintenance routines will be part of the operating environment.

Understand the inspection environment

The specification gives market regulation authorities a technical basis for metrology inspections of medical equipment. Companies operating in China should keep documentation and calibration records organized so that inspections and partner audits can be handled efficiently.

How ChinaMNC Can Help

Navigating China's medical device and metrology landscape while setting up or running a company can be complex for foreign founders. ChinaMNC supports foreign founders with company registration and ongoing operations in China. To discuss your situation, contact ChinaMNC on WhatsApp or WeChat at +86 153 1898 8535.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.